Home > Press > Congressional Nanotechnology Caucus Seeks Members
Abstract:
In a May 2011 letter, Representatives Hall and Johnson ask Congressional members to join the Congressional Nanotechnology Caucus. The Caucus was formed over ten years ago and is intended to inform legislators about nanotechnology issues.
In a May 2011 letter, Representatives Ralph M. Hall (R-TX) and Eddie Bernice Johnson (D-TX) ask Congressional members to join the bipartisan and bicameral Congressional Nanotechnology Caucus. The Caucus was formed over ten years ago and is intended to inform legislators about nanotechnology issues, including the effect of nanotechnology on job creation and other economic benefits to the U.S. The National Nanotechnology Initiative (NNI), which was codified by Congress in 2003, coordinates the federal nanotechnology research and development of 25 federal agencies. Since enactment, the House has passed bills in the 110th (H.R. 5940) and 111th (H.R. 554 and H.R. 5116) Congresses to amend and reauthorize the NNI, but the Senate did not act in either Congress. Since fiscal year 2008, the NNI has received funding through annual appropriations bills. Nanotechnology stakeholders are urged to use this template letter nanotech.lawbc.com/uploads/fi
le/00076693(1).doc to let their representatives and senators know of the importance of nanotechnology issues to their constituents and urge them to participate in the Caucus.
####
About Bergeson & Campbell, P.C.
Bergeson & Campbell, P.C. is an AV-rated (highest ranking) Washington, D.C. law firm focusing on conventional and nanoscale, industrial, agricultural, and specialty chemical product regulation and approval matters, including TSCA matters, FIFRA/FQPA matters, FDA medical device and product approval, registration and data compensation arbitrations, chemical product litigation, and associated business counseling and litigation issues. Bergeson & Campbell's clients are involved in many businesses, including conventional and nanoscale, basic, specialty, and agricultural and antimicrobial chemicals; biotechnology, nanotechnology, and emerging transformative technologies; pharmaceuticals, medical devices, and diagnostic products; fibers; paints and coatings; printing and publishing; and plastic products.
For more information, please click here
Contacts:
Lynn L. Bergeson
1203 Nineteenth Street, N.W., Suite 300
Washington, District of Columbia 20036 USA
Copyright © Bergeson & Campbell, P.C.
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Simulating magnetization in a Heisenberg quantum spin chain April 5th, 2024
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Govt.-Legislation/Regulation/Funding/Policy
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Chemical reactions can scramble quantum information as well as black holes April 5th, 2024
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Alliances/Trade associations/Partnerships/Distributorships
Chicago Quantum Exchange welcomes six new partners highlighting quantum technology solutions, from Chicago and beyond September 23rd, 2022
University of Illinois Chicago joins Brookhaven Lab's Quantum Center June 10th, 2022
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||